The Smad4/PTEN Expression Pattern Predicts Clinical Outcomes in Colorectal Adenocarcinoma

키워드

참고문헌 (43)

1. Torre LA, "Global cancer statistics, 2012", CA Cancer J Clin, 65, pp.87~108 (2015)[DOI]
2. Cunningham D, "Colorectal cancer", Lancet, 375, pp.1030~1047 (2010)[DOI]
3. Vogelstein B, "Genetic alterations during colorectal-tumor development", N Engl J Med, 319, pp.525~532 (1988)[DOI]
4. Valcz G, "Increase of alpha-SMA(+) and CK (+) cells as an early sign of epithelial-mesenchymal transition during colorectal carcinogenesis", Pathol Oncol Res, 18, pp.371~376 (2012)[DOI]
5. Ionov Y, "Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis", Nature, 363, pp.558~561 (1993)[DOI]
6. Peltomaki P, "Role of DNA mismatch repair defects in the pathogenesis of human cancer", J Clin Oncol, 21, pp.1174~1179 (2003)[DOI]
7. Boland CR, "Microsatellite instability in colorectal cancer", Gastroenterology, 138, pp.2073~2087 (2010)[DOI]
8. Wood LD, "The genomic landscapes of human breast and colorectal cancers", Science, 318, pp.1108~1113 (2007)[DOI]
9. Starr TK, "A transposon-based genetic screen in mice identifies genes altered in colorectal cancer", Science, 323, pp.1747~1750 (2009)[DOI]
10. Segditsas S, "Colorectal cancer and genetic alterations in the Wnt pathway", Oncogene, 25, pp.7531~7537 (2006)[DOI]
11. Guinney J, "The consensus molecular subtypes of colorectal cancer", Nat Med, 21, pp.1350~1356 (2015)[DOI]
12. Choi D, "Cancer stem cell markers CD133 and CD24 correlate with invasiveness and differentiation in colorectal adenocarcinoma", World J Gastroenterol, 15, pp.2258~2264 (2009)[DOI]
13. Jing F, "Colon cancer stem cell markers CD44 and CD133 in patients with colorectal cancer and synchronous hepatic metastases", Int J Oncol, 46, pp.1582~1588 (2015)[DOI]
14. Sahlberg SH, "Evaluation of cancer stem cell markers CD133, CD44, CD24: association with AKT isoforms and radiation resistance in colon cancer cells", PLoS One, 9, pp.e94621~ (2014)[DOI]
15. Chen KL, "Highly enriched CD133(+)CD44(+) stem-like cells with CD133(+)CD44(high) metastatic subset in HCT116 colon cancer cells", Clin Exp Metastasis, 28, pp.751~763 (2011)[DOI]
16. Kechagioglou P, "Tumor suppressor PTEN in breast cancer: heterozygosity, mutations and protein expression", Anticancer Res, 34, pp.1387~1400 (2014)
17. Saal LH, "Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair", Nat Genet, 40, pp.102~107 (2008)[DOI]
18. Wang X, "The PTEN tumor suppressor gene and its role in lymphoma pathogenesis", Aging (Albany NY), 7, pp.1032~1049 (2015)
19. Zhang LL, "Phosphatase and tensin homolog (PTEN) represses colon cancer progression through inhibiting paxillin transcription via PI3K", AKT, J Biol Chem, pp.2015, 290[DOI]
20. 박성혜, "Molecular Testing of Brain Tumor", Journal of Pathology and Translational Medicine, 51(3), pp.205~223 (2017), 대한병리학회[DOI]
21. Miyaki M, "Role of Smad4 (DPC4) inactivation in human cancer", Biochem Biophys Res Commun, 306, pp.799~804 (2003)[DOI]
22. Xu X, "Induction of intrahepatic cholangiocellular carcinoma by liver-specific disruption of Smad4 and Pten in mice", J Clin Invest, 116, pp.1843~1852 (2006)[DOI]
23. Chow JY, "TGFbeta modulates PTEN expression independently of SMAD signaling for growth proliferation in colon cancer cells", Cancer Biol Ther, 7, pp.1694~1699 (2008)[DOI]
24. Ding Z, "SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression", Nature, 470, pp.269~273 (2011)[DOI]
25. Teng Y, "Synergistic function of Smad4 and PTEN in suppressing forestomach squamous cell carcinoma in the mouse", Cancer Res, 66, pp.6972~6981 (2006)[DOI]
26. Yan P, "Reduced expression of SMAD4 is associated with poor survival in colon cancer", Clin Cancer Res, 22, pp.3037~3047 (2016)[DOI]
27. Liu J, "ErbB2 pathway activation upon Smad4 loss promotes lung tumor growth and metastasis", Cell Rep, 10, pp.1599~1613 (2015)[DOI]
28. Xu X, "Synergistic action of Smad4 and PTEN in suppressing pancreatic ductal adenocarcinoma formation in mice", Oncogene, 29, pp.674~686 (2010)[DOI]
29. Jang KS, "Clinicopathological significance of nuclear PTEN expression in colorectal adenocarcinoma", Histopathology, 56, pp.229~239 (2010)[DOI]
30. Peppercorn J, "Molecular subtypes in breast cancer evaluation and management: divide and conquer", Cancer Invest, 26, pp.1~10 (2008)[DOI]
31. Stambolic V, "Negative regulation of PKB", Akt-dependent cell survival by the tumor suppressor PTEN, 1998, pp.95, 29~39
32. Davies MA, "Regulation of Akt", PKB activity, cellular growth, and apoptosis in prostate carcinoma cells by MMAC, Cancer Res, pp.1999, 59[DOI]
33. Haeger SM, "Smad4 loss promotes lung cancer formation but increases sensitivity to DNA topoisomerase inhibitors", Oncogene, 35, pp.577~586 (2016)[DOI]
34. Ahmed S, "The TGF-beta", Smad4 signaling pathway in pancreatic carcinogenesis and its clinical significance, 2017, pp.6, 5~
35. Tachibana M, "Expression and prognostic significance of PTEN product protein in patients with esophageal squamous cell carcinoma", Cancer, 94, pp.1955~1960 (2002)[DOI]
36. Lee HS, "Tumour suppressor gene expression correlates with gastric cancer prognosis", J Pathol, 200, pp.39~46 (2003)[DOI]
37. Li J, "PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer", Science, 275, pp.1943~1947 (1997)[DOI]
38. Zhao Y, "Loss of phosphatase and tensin homolog expression correlates with clinicopathological features of non-small cell lung cancer patients and its impact on survival: a systematic review and meta-analysis", Thorac Cancer, 8, pp.203~213 (2017)[DOI]
39. Risinger JI, "PTEN", MMAC1 mutations in endometrial cancers, 1997, pp.57, 4736~4738
40. Yang L, "PTEN encoding product: a marker for tumorigenesis and progression of gastric carcinoma", World J Gastroenterol, 9, pp.35~39 (2003)[DOI]
41. Dicuonzo G, "Colorectal carcinomas and PTEN", MMAC1 gene mutations, 2001, pp.7, 4049~4053
42. Guanti G, "Involvement of PTEN mutations in the genetic pathways of colorectal cancerogenesis", Hum Mol Genet, 9, pp.283~287 (2000)[DOI]
43. Reynisdottir I, "Kip", Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta, 1995, pp.9, 1831~1845

관련 논문AI추천